Watch Ticker

Eli Lilly & Co.

Go to Eli Lilly & Co. Website

$762.33

22.26 (3.01%)

Live

Previous Close

$762.33

Day Range

$745.99 - $768

Previous Day Range

$735.44 - $766.4468

Market Cap

$684.4 billion USD

Day Vol.

4.9 million

Previous Day Vol.

5.8 million

Currency

USD

Primary Exchange

New York Stock Exchange

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Community

0 posts discussing

2

Watchers

11

Visitors

Recent News

Eric Volkman - Why Novo Nordisk Stock Bumped Higher on Friday

The Trump administration is considering an experimental program to subsidize weight-loss drug costs through Medicare and Medicaid, which could significantly benefit pharmaceutical companies developing obesity medications.

Related tickers: NVO, LLY.

Read Full Article

Vandana Singh - Trump Administration Plan Signals Shift Toward Weight-Loss Drug Coverage For Medicare Patients

The Trump administration is developing a pilot program to potentially allow Medicare and Medicaid coverage for weight-loss medications like GLP-1 drugs, with estimated costs around $35 billion between 2026 and 2034.

Related tickers: NVO, LLY.

Read Full Article

Trending Tickers

Please sign in to view